Start low (50 mg/day), monitor your bodys response, and increase gradually if needed
In STEP 1, participants without diabetes who received semaglutide 2.4 mg weekly lost an average of 14.9% of their body weight over 68 weeks compared to 2.4% with placebo
Growth Factor Activation BPC-157 has been shown to upregulate growth factor receptors, including those involved in tendon-to-bone healing and soft tissue repair
Fortunately, the 0.9% benzyl alcohol acts as a preservative
People notice a reduction in stored fat, faster metabolism, improved fat burning, higher energy levels, enhanced gallbladder, and liver function, lean body mass preservation, liver detoxification, enhanced nutrient absorption, and increased mental clarity
After this period, we recommend discarding it to ensure safety and efficacy